Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery

Cardiology (Switzerland)

Volumn 131, Issue 1, 2015, Pages 30-37

  Xia, Jinggang ^a   Qu, Yang ^b   Yin, Chunlin ^a   Xu, Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Long term statin therapy; Major adverse cardiovascular and cerebrovascular events; Noncardiac emergency surgery; Rosuvastatin reload; Stable coronary artery disease

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CREATINE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN; PLACEBO; ROSUVASTATIN; SIMVASTATIN; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG WITHDRAWAL; EMERGENCY SURGERY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART PROTECTION; HUMAN; INCIDENCE; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; RISK REDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; COMPLICATION; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL;

AGED; CORONARY ARTERY DISEASE; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PYRIMIDINES; SULFONAMIDES;

EID: 84926177139     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000371872     Document Type: Article

References (24)

1. Mangano DT: Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-184.
2. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: e418-e499.
3. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA: Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996; 57: 37-44.
4. Cohen MC, Aretz TH: Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999; 8: 133-139.
5. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al: ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
6. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al: 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123:e426-e579.
7. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al: 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271-2306.
8. Nafasi L, Rahmani R, Shafiee A, Salari A, Abdollahi A, Meysamie A: Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction. Curr Med Res Opin 2014; 30: 381-386.
9. Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leao P, Caramelli B: Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39: 967-975; discussion 975-976.
10. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G: Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia after Cardiac Surgery) study. Circulation 2006; 114: 1455-1461.
11. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al: Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-1598.
12. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A: Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDARECAPTURE (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) randomized trial. J Am Coll Cardiol 2009; 54: 558-565.
13. Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, De Hert S, et al: 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2014, Epub ahead of print.
14. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al: 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64:e77-e137.
15. Xia JG, Qu Y, Shen H, Liu XH: Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction. Coron Artery Dis 2013; 24: 522-526.
16. Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS, Washam JB, Fleischmann KE, Fleisher LA: Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64: 2406-2425.
17. Sadowitz B, Maier KG, Gahtan V: Basic science review: statin therapy-part I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg 2010; 44: 241-251.
18. Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, et al: Determinants of residual risk in secondary prevention patients treated with high-versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation 2012; 125: 1979-1987.
19. Hahn JY, Kim HJ, Choi YJ, Jo SH, Kim HJ, Lee S, Ahn KJ, Song YB, Choi JH, Choi SH, Choi YJ, Lee KH, Lee SH, Gwon HC: Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J 2011; 162: 1026-1033.
20. Rosenson RS, Tangney CC: Antiatherothrombotic properties of statins: implication for cardiovascular event reduction. JAMA 1998; 279: 1643-1650.
21. Davignon J: Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004; 109(suppl 1):III39-III43.
22. De Martino RR, Eldrup-Jorgensen J, Nolan BW, Stone DH, Adams J, Bertges DJ, Cronenwett JL, Goodney PP: Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery. J Vasc Surg 2014; 59: 1615-1621, 1621.e1.
23. Raju MG, Pachika A, Punnam SR, Gardiner JC, Shishehbor MH, Kapadia SR, Abela GS: Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery. Clin Cardiol 2013; 36: 456-461.
24. Iannuzzi JC, Rickles AS, Kelly KN, Rusheen AE, Dolan JG, Noyes K, Monson JR, Fleming FJ: Perioperative pleiotropic statin effects in general surgery. Surgery 2014; 155: 398-407.